{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:52Z","timestamp":1792090072851,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1245\/s10434-014-4365-3","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T17:12:54Z","timestamp":1422292374000},"page":"3102-3108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Intra-arterial Yttrium-90 Radioembolization Combined with Systemic Chemotherapy is a Promising Method for Downstaging Unresectable Huge Intrahepatic Cholangiocarcinoma to Surgical Treatment"],"prefix":"10.1245","volume":"22","author":[{"given":"M.","family":"Rayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. B.","family":"Levi Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Boudjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84\u201396.","journal-title":"Ann Surg."},{"key":"4365_CR2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215\u201329.","journal-title":"Gastroenterology."},{"key":"4365_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin."},{"key":"4365_CR4","doi-asserted-by":"crossref","unstructured":"Dodson RM, Weiss MJ, Cosgrove D, et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg. 2013;217:736\u201350e4.","DOI":"10.1016\/j.jamcollsurg.2013.05.021"},{"key":"4365_CR5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","volume":"33","author":"T Patel","year":"2001","unstructured":"Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353\u20137.","journal-title":"Hepatology."},{"key":"4365_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gcb.2010.01.006","volume":"34","author":"O Farges","year":"2010","unstructured":"Farges O, Fuks D. Clinical presentation and management of intrahepatic cholangiocarcinoma. Gastroenterol Clin Biol. 2010;34:191\u20139.","journal-title":"Gastroenterol Clin Biol."},{"key":"4365_CR7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","volume":"15","author":"JC Tan","year":"2008","unstructured":"Tan JC, Coburn NG, Baxter NN, et al. Surgical management of intrahepatic cholangiocarcinoma\u2014a population-based study. Ann Surg Oncol. 2008;15:600\u20138.","journal-title":"Ann Surg Oncol."},{"key":"4365_CR8","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/bjs.8953","volume":"99","author":"L Sulpice","year":"2012","unstructured":"Sulpice L, Rayar M, Boucher E, et al. Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg. 2012;99:1711\u20137.","journal-title":"Br J Surg."},{"key":"4365_CR9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","volume":"11","author":"H Nathan","year":"2007","unstructured":"Nathan H, Pawlik TM, Wolfgang CL, et al. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488\u201396.","journal-title":"J Gastrointest Surg."},{"key":"4365_CR10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1365-2168.2002.02268.x","volume":"89","author":"M Ohtsuka","year":"2002","unstructured":"Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525\u201331.","journal-title":"Br J Surg."},{"issue":"5 Suppl 1","key":"4365_CR11","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","volume":"127","author":"JF Geschwind","year":"2004","unstructured":"Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S194\u2013205.","journal-title":"Gastroenterology."},{"key":"4365_CR12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00330-008-1211-7","volume":"19","author":"MA Vente","year":"2009","unstructured":"Vente MA, Wondergem M, van der Tweel I, et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol. 2009;19:951\u20139.","journal-title":"Eur Radiol."},{"key":"4365_CR13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","volume":"113","author":"SM Ibrahim","year":"2008","unstructured":"Ibrahim SM, Mulcahy MF, Lewandowski RJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008;113:2119\u201328.","journal-title":"Cancer."},{"key":"4365_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","volume":"17","author":"A Saxena","year":"2010","unstructured":"Saxena A, Bester L, Chua TC, et al. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol. 2010;17:484\u201391.","journal-title":"Ann Surg Oncol."},{"key":"4365_CR15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00270-012-0463-4","volume":"36","author":"S Rafi","year":"2013","unstructured":"Rafi S, Piduru SM, El-Rayes B, et al. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol. 2013;36:440\u20138.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"4365_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","volume":"24","author":"S Mouli","year":"2013","unstructured":"Mouli S, Memon K, Baker T, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24:1227\u201334.","journal-title":"J Vasc Interv Radiol."},{"key":"4365_CR17","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1245\/s10434-013-2906-9","volume":"20","author":"J Edeline","year":"2013","unstructured":"Edeline J, Lenoir L, Boudjema K, et al. Volumetric changes after (90)Y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol. 2013;20:2518\u201325.","journal-title":"Ann Surg Oncol."},{"key":"4365_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol."},{"key":"4365_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SLA.0b013e31825a01f6","volume":"257","author":"SM Strasberg","year":"2013","unstructured":"Strasberg SM, Phillips C. Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257:377\u201382.","journal-title":"Ann Surg."},{"key":"4365_CR20","first-page":"760","volume":"44","author":"FF Chou","year":"1997","unstructured":"Chou FF, Sheen-Chen SM, Chen YS, et al. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology. 1997;44:760\u20135.","journal-title":"Hepatogastroenterology."},{"key":"4365_CR21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med."},{"key":"4365_CR22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000098109","volume":"70","author":"T Kiba","year":"2006","unstructured":"Kiba T, Nishimura T, Matsumoto S, et al. Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. Oncology. 2006;70:358\u201365.","journal-title":"Oncology."},{"key":"4365_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.coc.0000203742.22828.bb","volume":"29","author":"GW Lee","year":"2006","unstructured":"Lee GW, Kang JH, Kim HG, et al. Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol. 2006;29:127\u201331.","journal-title":"Am J Clin Oncol."},{"key":"4365_CR24","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","volume":"23","author":"JJ Knox","year":"2005","unstructured":"Knox JJ, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol. 2005;23:2332\u20138.","journal-title":"J Clin Oncol."},{"key":"4365_CR25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"T Andre","year":"2004","unstructured":"Andre T, Tournigand C, Rosmorduc O, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol. 2004;15:1339\u201343.","journal-title":"Ann Oncol."},{"key":"4365_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00270-011-0142-x","volume":"35","author":"RT Hoffmann","year":"2012","unstructured":"Hoffmann RT, Paprottka PM, Schon A, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol. 2012;35:105\u201316.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"4365_CR27","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","volume":"20","author":"O Hyder","year":"2013","unstructured":"Hyder O, Marsh JW, Salem R, et al. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann Surg Oncol. 2013;20:3779\u201386.","journal-title":"Ann Surg Oncol."},{"key":"4365_CR28","doi-asserted-by":"crossref","unstructured":"Benson AB 3rd, Geschwind JF, Mulcahy MF, et al. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. Eur J Cancer. 2013;49:3122\u201330.","DOI":"10.1016\/j.ejca.2013.05.012"},{"key":"4365_CR29","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3748\/wjg.v20.i17.5131","volume":"20","author":"C Servajean","year":"2014","unstructured":"Servajean C, Gilabert M, Piana G, et al. One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization. World J Gastroenterol. 2014;20:5131\u20134.","journal-title":"World J Gastroenterol."},{"key":"4365_CR30","doi-asserted-by":"crossref","unstructured":"Henry LR, Hostetter RB, Ressler B, et al. Liver resection for metastatic disease after Y90 radioembolization: a case series with long-term follow-up. Ann Surg Oncol. 2015;22:467\u201374.","DOI":"10.1245\/s10434-014-4012-z"},{"key":"4365_CR31","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.transproceed.2014.09.057","volume":"46","author":"W Patkowski","year":"2014","unstructured":"Patkowski W, Stankiewicz R, Grat M, et al. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization. Transplant Proc. 2014;46:2774\u20136.","journal-title":"Transplant Proc."},{"key":"4365_CR32","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31:1188\u201395.","journal-title":"J Clin Oncol."},{"key":"4365_CR33","doi-asserted-by":"crossref","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565\u2013574.","DOI":"10.1001\/jamasurg.2013.5137"},{"key":"4365_CR34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s13244-013-0268-2","volume":"4","author":"R Albazaz","year":"2013","unstructured":"Albazaz R, Patel CN, Chowdhury FU, Scarsbrook AF. Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours. Insights Imaging. 2013;4:691\u2013700.","journal-title":"Insights Imaging."},{"key":"4365_CR35","doi-asserted-by":"crossref","first-page":"247693","DOI":"10.1155\/2014\/247693","volume":"2014","author":"S Annunziata","year":"2014","unstructured":"Annunziata S, Caldarella C, Pizzuto DA, et al. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis. Biomed Res Int. 2014;2014:247693.","journal-title":"Biomed Res Int."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4365-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4365-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4365-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T04:16:38Z","timestamp":1566274598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4365-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4365-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}